Network meta-analyses performed by contracting companies and commissioned by industry

Systematic Reviews

Volumn 5, Issue 1, 2016, Pages

  Schuit, Ewoud ^a   Ioannidis, John P A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Contracting company; Industry; Network meta analysis; Non publication; Protocol registration; Publication bias; Transparency

Indexed keywords

ARTICLE; BIBLIOGRAPHIC DATABASE; BIOMEDICAL TECHNOLOGY ASSESSMENT; CONTRACT; DRUG INDUSTRY; HEALTH CARE SURVEY; HUMAN; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PRIORITY JOURNAL; PUBLISHING; REGISTRATION; INDUSTRY; META ANALYSIS (TOPIC); NETWORK META-ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC);

CONTRACTS; HUMANS; INDUSTRY; META-ANALYSIS AS TOPIC; NETWORK META-ANALYSIS; PUBLICATION BIAS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 84997234823     PISSN: None     EISSN: 20464053     Source Type: Journal    
DOI: 10.1186/s13643-016-0377-3     Document Type: Article

References (23)

1. Bucher HC, Guyatt GH, Griffith LE, Walter SD. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol. 1997;50:683-91.
2. Higgins JP, Whitehead A. Borrowing strength from external trials in a meta-analysis. Stat Med. 1996;15:2733-49.
3. Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med. 2004;23:3105-24.
4. Chambers JD, Naci H, Wouters OJ, Pyo J, Gunjal S, Kennedy IR, et al. An assessment of the methodological quality of published network meta-analyses: a systematic review. PLoS ONE. 2015;10, e0121715.
5. International Society for Pharmacoeconomics and Outcomes Research. ISPOR 20th Annual International Meeting list of exhibitors ( http://www.ispor.org/Event/Exhibitors/2015Philadelphia ). 5-4-2015. 5-4-2015.
6. Centre for Reviews and Dissemination. PROSPERO ( http://www.crd.york.ac.uk/PROSPERO/ ). 6-29-0015. 11-23-2015.
7. Booth A, Clarke M, Dooley G, Ghersi D, Moher D, Petticrew M, et al. The nuts and bolts of PROSPERO: an international prospective register of systematic reviews. Syst Rev. 2012;1:2.
8. Asch DA, Jedrziewski MK, Christakis NA. Response rates to mail surveys published in medical journals. J Clin Epidemiol. 1997;50:1129-36.
9. Chapman SJ, Shelton B, Mahmood H, Fitzgerald JE, Harrison EM, Bhangu A. Discontinuation and non-publication of surgical randomised controlled trials: observational study. BMJ. 2014;349:g6870.
10. Jones CW, Handler L, Crowell KE, Keil LG, Weaver MA, Platts-Mills TF. Non-publication of large randomized clinical trials: cross sectional analysis. BMJ. 2013;347:f6104.
11. Manzoli L, Flacco ME, D'Addario M, Capasso L, De VC, Marzuillo C, et al. Non-publication and delayed publication of randomized trials on vaccines: survey. BMJ. 2014;348:g3058.
12. Ross JS, Mulvey GK, Hines EM, Nissen SE, Krumholz HM. Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis. PLoS Med. 2009;6:e1000144.
13. Ross JS, Tse T, Zarin DA, Xu H, Zhou L, Krumholz HM. Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis. BMJ. 2012;344:d7292.
14. Djulbegovic B, Kumar A, Miladinovic B, Reljic T, Galeb S, Mhaskar A, et al. Treatment success in cancer: industry compared to publicly sponsored randomized controlled trials. PLoS ONE. 2013;8, e58711.
15. Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L. Industry sponsorship and research outcome. Cochrane Database Syst Rev. 2012;12, MR000033.
16. Kondro W, Sibbald B. Drug company experts advised staff to withhold data about SSRI use in children. CMAJ. 2004;170:783.
17. Siontis KC, Hernandez-Boussard T, Ioannidis JP. Overlapping meta-analyses on the same topic: survey of published studies. BMJ. 2013;347:f4501.
18. Ioannidis JP. Stealth research: is biomedical innovation happening outside the peer-reviewed literature? JAMA. 2015;313:663-4.
19. Palepu A, Kendall C, Moher D. Open Medicine endorses PROSPERO. Open Med. 2011;5:e65-6.
20. Cochrane Comparing Multiple Interventions Methods Group. http://methods.cochrane.org/cmi/comparing-multiple-interventions-cochrane-reviews. 2016.
21. Ioannidis JP, Greenland S, Hlatky MA, Khoury MJ, Macleod MR, Moher D, et al. Increasing value and reducing waste in research design, conduct, and analysis. Lancet. 2014;383:166-75.
22. Stewart L, Moher D, Shekelle P. Why prospective registration of systematic reviews makes sense. Syst Rev. 2012;1:7.
23. Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162:777-84.